Abbott Laboratories Revenue 2006-2018 | ABT

Current and historical revenue for Abbott Laboratories (ABT) from 2006 to 2018. Revenue can be defined as the sum of all revenue fields included for a company's operating activities. Abbott Laboratories revenue for the twelve months ending June 30, 2018 was $29.575B. Abbott Laboratories revenue for the three months ending June 30, 2018 was $7.767B, representing a 17.03% increase from the same quarter last year.
Abbott Laboratories Annual Revenue
(Millions of US $)
2017 $27,390
2016 $20,853
2015 $20,405
2014 $20,247
2013 $19,657
2012 $19,050
2011 $21,407
2010 $35,167
2009 $30,765
2008 $29,528
2007 $25,914
2006 $22,476
2005 $22,338
Abbott Laboratories Quarterly Revenue
(Millions of US $)
Q2 2018 $7,767
Q1 2018 $7,390
Q4 2017 $7,589
Q3 2017 $6,829
Q2 2017 $6,637
Q1 2017 $6,335
Q4 2016 $5,333
Q3 2016 $5,302
Q2 2016 $5,333
Q1 2016 $4,885
Q4 2015 $5,188
Q3 2015 $5,150
Q2 2015 $5,170
Q1 2015 $4,897
Q4 2014 $5,356
Q3 2014 $5,079
Q2 2014 $5,057
Q1 2014 $4,755
Q4 2013 $4,008
Q3 2013 $4,825
Q2 2013 $5,446
Q1 2013 $5,378
Q4 2012 $3,188
Q3 2012 $5,265
Q2 2012 $5,313
Q1 2012 $5,284
Q4 2011 $10,377
Q3 2011 $9,817
Q2 2011 $9,616
Q1 2011 $9,041
Q4 2010 $9,968
Q3 2010 $8,675
Q2 2010 $8,826
Q1 2010 $7,698
Q4 2009 $8,790
Q3 2009 $7,761
Q2 2009 $7,495
Q1 2009 $6,718
Q4 2008 $7,950
Q3 2008 $7,498
Q2 2008 $7,314
Q1 2008 $6,766
Q4 2007 $7,221
Q3 2007 $6,377
Q2 2007 $6,371
Q1 2007 $5,946
Q4 2006 $6,821
Q3 2006 $5,574
Q2 2006 $5,501
Q1 2006 $4,580
Q4 2005 $6,047
Q3 2005 $5,384
Q2 2005 $5,524
Q1 2005 $5,383
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $112.329B $27.390B
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $122.465B 18.95
Stryker (SYK) United States $62.038B 23.97
Boston Scientific (BSX) United States $46.397B 24.14
Baxter (BAX) United States $38.200B 26.00
Zimmer Biomet Holdings (ZBH) United States $24.941B 16.02
Smith & Nephew SNATS (SNN) United Kingdom $15.395B 0.00
ResMed (RMD) United States $15.384B 30.53
Perrigo (PRGO) Ireland $9.565B 13.57
Bio-Rad Laboratories (BIO) United States $9.531B 61.26
Hill-Rom Holdings (HRC) United States $6.308B 21.40
Canopy Growth (CGC) Canada $6.230B 0.00
ICU Medical (ICUI) United States $5.941B 40.56
Haemonetics (HAE) United States $5.156B 47.05
Insulet (PODD) United States $5.134B 0.00
Agios Pharmaceuticals (AGIO) United States $4.432B 0.00
Hutchison China MediTech (HCM) China $4.374B 0.00
Neogen (NEOG) United States $4.327B 68.95
GW Pharmaceuticals (GWPH) United Kingdom $3.748B 0.00
National Vision Holdings (EYE) United States $3.382B 0.00
NuVasive (NUVA) United States $3.320B 31.49
Quidel (QDEL) United States $2.722B 55.76
Phibro Animal Health (PAHC) United States $1.978B 29.37
NxStage Medical (NXTM) United States $1.856B 0.00
Cardiovascular Systems (CSII) United States $1.252B 752.80
Eagle Pharmaceuticals (EGRX) United States $1.195B 35.26
AtriCure (ATRC) United States $1.103B 0.00
VAREX IMAGING (VREX) United States $1.075B 17.57
OraSure Technologies (OSUR) United States $1.025B 67.04
Orthofix (OFIX) United States $1.012B 30.83
TG Therapeutics (TGTX) United States $0.981B 0.00
Cerus (CERS) United States $0.958B 0.00
Surmodics (SRDX) United States $0.941B 113.63
MacroGenics (MGNX) United States $0.901B 0.00
Owens & Minor (OMI) United States $0.879B 9.41
Omeros (OMER) United States $0.861B 0.00
LeMaitre Vascular (LMAT) United States $0.706B 33.87
PetIQ (PETQ) United States $0.665B 0.00
Meridian Bioscience (VIVO) United States $0.636B 21.74
Insys Therapeutics (INSY) United States $0.554B 0.00
Evolus (EOLS) United States $0.554B 0.00
Lantheus Holdings (LNTH) United States $0.502B 15.60
NanoString Technologies (NSTG) United States $0.417B 0.00
Cytosorbents (CTSO) United States $0.363B 0.00
Utah Medical Products (UTMD) United States $0.340B 21.90
BioLife Solutions (BLFS) United States $0.325B 0.00
Quanterix (QTRX) United States $0.323B 0.00
Surface Oncology (SURF) United States $0.287B 0.00
Rockwell Medical (RMTI) United States $0.244B 0.00
Chimerix (CMRX) United States $0.210B 0.00
Fonar (FONR) United States $0.169B 10.25
Chembio Diagnostics (CEMI) United States $0.162B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.122B 0.00
Female Health (VERU) United States $0.117B 0.00
Trinity Biotech (TRIB) Ireland $0.093B 27.88
United-Guardian (UG) United States $0.086B 18.95
Oramed Pharmaceuticals (ORMP) Israel $0.083B 0.00
CAS Medical Systems (CASM) United States $0.077B 0.00
Neurotrope (NTRP) United States $0.076B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.065B 0.00
Valeritas Holdings (VLRX) United States $0.038B 0.00
ImmuCell (ICCC) United States $0.036B 0.00
Capricor Therapeutics (CAPR) United States $0.032B 0.00
Akers Biosciences Inc (AKER) United States $0.026B 0.00
Senestech (SNES) United States $0.018B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Cellectar Biosciences (CLRB) United States $0.007B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.003B 0.00